期刊文献+

雷替曲塞与5-氟尿嘧啶毒副反应对比的药物临床研究 被引量:7

Comparison of Toxicities of Raltitrexed and 5-Fluorouracil
下载PDF
导出
摘要 目的探究与分析雷替曲塞与5-氟尿嘧啶毒副反应对比结果。方法 60例晚期结直肠癌患者采取随机数字表法分成试验组和对照组,试验组采用雷替曲塞进行治疗,对照组采用5-氟尿嘧啶进行治疗。观察并比较2组患者经不同治疗方式后的临床效果及毒副反应。结果试验组患者经治疗后的有效人数高于对照组36.67%(P<0.05)。试验组患者出现呕吐、神经毒性、脱发的人数较对照组明显减少,分别少26.67%、26.66%、26.66%(P<0.05)。结论雷替曲塞治疗方案更适于用晚期结直肠癌患者,具有高效低毒的优势,值得在临床范围内广泛推广。 Objective To discuss and study the toxicities of rahitrexed and 5-fluorouracil. Methods Sixty pa- tients with advanced colorectal cancer were divided into the experimental group and the control group according to random number table, the patients of the experimental group adopted raltitrexed, and the patients of the control group adopted 5-fluorouracil. The efficacy and toxicities of the two groups were compared. Results The effective number in the experimental group was higher than that of the control group (36.67%, P 〈0.05). The number of patients who occurred vomit, neurovirulence and baldness in the experimental group were fewer than those of the control group, respectively (26.67%, 26.66% and 26.66%, P 〈 0.05 ). Conclusion Raltitrexed is more suit- able for patients with advanced colorectal cancer, because it produces smaller toxicities, and has the good efficacy.
作者 刘孟兴
出处 《肿瘤基础与临床》 2013年第5期434-436,共3页 journal of basic and clinical oncology
关键词 雷替曲塞 5-氟尿嘧啶 毒副反应 rahitrexed 5-fluorouracil toxicity
  • 相关文献

参考文献10

二级参考文献143

共引文献186

同被引文献61

  • 1LochanR, White SA, Manas DS. Liver resection for colorectal liver metastasis [J]. Surg Oncol, 2007, 16 (1) : 33 -45. 被引量:1
  • 2Maughan T, James R, Kerr D, et al. Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5 - Fu regimen in thhe palliative chemotherapy of ad- vanced colorectal cancer ( CRC ) : final results of MRC CRO6 [Jl. AnnOncol, 2000, 11 (4): 1850. 被引量:1
  • 3Cortinovis D, Bajetta E, Di Bartolomeo M, et al. Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer [Jl. Tumori, 2004, 90 (2): 186-191. 被引量:1
  • 4Laudani A, Gebbia V, Leonardi V, et al. Activity and toxicity of oxaliplatin plus raltitrexed in 5 - fluorouracil - refractory meta- static colorectal adeno - carcinoma [ J]. Anticancer Res, 2004, 24 (2C): 1139-1142. 被引量:1
  • 5Khouri C, Guiu B, Cereueil JP, et al. Rahitrexed and oxali- platin hepatic arterial infusion for advanced colorectal cancer: a retrospective study [ J]. Anticancer Drugs, 2010, 21 (6) : 656 - 661. 被引量:1
  • 6Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin, 2011 Mar-Apr,61 (2) :69 - 90. 被引量:1
  • 7Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014 [J]. CA Cancer J Clin, 2014,64(2) :104 - 117. 被引量:1
  • 8Larsen IK, Bray F. Trends in colorectal cancer incidence in Norway 1962-2006 : an interpretation of the temporal patterns by anatomic subsite [ J ]. Int J Cancer, 2010,126 ( 3 ) :721 - 732. 被引量:1
  • 9Sobrero A, Guglielmi A, Grossi F,et M. Mechanism of action of flu- oropyrimidines: relevance to the new developments in co|orectal cancer chemotherapy [ J ]. Scmin Oncol, 2000,27 (5 Suppl 10 ) :72 -77. 被引量:1
  • 10Pooh MA, OConnell MJ ,Wieand HS ,et al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer[ J]. J Clin On-col,1991,9(11):1967-1972. 被引量:1

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部